BANK OF AMERICA CORP /DE/ - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 59 filers reported holding PROQR THRAPEUTICS N V in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$140,839
-43.7%
108,338
-29.9%
0.00%
Q2 2023$250,267
-23.2%
154,486
+1.0%
0.00%
Q1 2023$325,743
+172.0%
152,931
+372.5%
0.00%
Q4 2022$119,750
+399.0%
32,365
+0.0%
0.00%
Q3 2022$24,000
-11.1%
32,353
-6.2%
0.00%
Q2 2022$27,000
+50.0%
34,507
+76.4%
0.00%
Q1 2022$18,000
-98.8%
19,561
-89.6%
0.00%
Q4 2021$1,506,000
+142.1%
187,896
+152.8%
0.00%
Q3 2021$622,000
+5554.5%
74,338
+4494.4%
0.00%
Q2 2021$11,000
-92.5%
1,618
-92.7%
0.00%
Q1 2021$147,000
+950.0%
22,169
+577.1%
0.00%
Q4 2020$14,000
-88.1%
3,274
-86.7%
0.00%
Q3 2020$118,000
+5800.0%
24,550
+10481.9%
0.00%
Q4 2019$2,000
-91.7%
232
-91.5%
0.00%
Q2 2019$24,000
+60.0%
2,740
+150.9%
0.00%
Q1 2019$15,000
-48.3%
1,092
-42.2%
0.00%
Q4 2018$29,000
+480.0%
1,890
+656.0%
0.00%
Q3 2018$5,000
+150.0%
2500.0%0.00%
Q2 2018$2,000
+100.0%
2500.0%0.00%
Q1 2018$1,000
-50.0%
250
+150.0%
0.00%
Q4 2014$2,0001000.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders